Portfolio Holdings Detail for ISIN IE00BD45YS76
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Core MSCI World UCITS ETF GBP Hedged (Dist)
IssuerBlackrock
ETF TickerIWDG(GBX) LSE
ETF TickerIWDG.LS(GBX) CXE
ETF TickerIWDG.L(GBP) LSE

Holdings detail for RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

Show aggregate RPRX holdings

News associated with RPRX

Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.
(RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
Analysts Predict 10% Gains Ahead For The Holdings of EUSA
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52

iShares Core MSCI World UCITS ETF GBP Hedged (Dist) RPRX holdings

DateNumber of RPRX Shares HeldBase Market Value of RPRX SharesLocal Market Value of RPRX SharesChange in RPRX Shares HeldChange in RPRX Base ValueCurrent Price per RPRX Share HeldPrevious Price per RPRX Share Held
2026-02-09 (Monday)686,977USD 30,261,337USD 30,261,337
2026-02-06 (Friday)686,977RPRX holding increased by 4233USD 30,673,523RPRX holding increased by 1752487USD 30,673,5234,233USD 1,752,487 USD 44.65 USD 42.36
2026-02-02 (Monday)682,744USD 28,921,036RPRX holding increased by 464266USD 28,921,0360USD 464,266 USD 42.36 USD 41.68
2026-01-30 (Friday)682,744USD 28,456,770RPRX holding increased by 559850USD 28,456,7700USD 559,850 USD 41.68 USD 40.86
2026-01-29 (Thursday)682,744USD 27,896,920RPRX holding increased by 81929USD 27,896,9200USD 81,929 USD 40.86 USD 40.74
2026-01-27 (Tuesday)682,744USD 27,814,991RPRX holding increased by 184341USD 27,814,9910USD 184,341 USD 40.74 USD 40.47
2026-01-26 (Monday)682,744USD 27,630,650RPRX holding increased by 47792USD 27,630,6500USD 47,792 USD 40.47 USD 40.4
2026-01-23 (Friday)682,744USD 27,582,858RPRX holding increased by 197996USD 27,582,8580USD 197,996 USD 40.4 USD 40.11
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RPRX by Blackrock for IE00BD45YS76

Show aggregate share trades of RPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY4,233 44.650* -
2026-01-15BUY40440.33539.560 39.638USD 16,014 -
2026-01-14BUY1,01040.58039.920 39.986USD 40,386 -
2026-01-08BUY1,20041.70039.980 40.152USD 48,182 -
2026-01-07BUY70741.40540.640 40.716USD 28,787 -
2026-01-06BUY90940.81039.680 39.793USD 36,172 -
2026-01-05BUY1,11139.86538.530 38.663USD 42,955 -
2025-12-19SELL-1,20038.80538.200 38.261USD -45,913 -
2025-12-17BUY2,30038.89538.300 38.359USD 88,227 -
2025-12-16BUY40038.66537.830 37.914USD 15,165 -
2025-12-15BUY50038.58038.028 38.083USD 19,042 -
2025-12-12BUY57038.93037.975 38.070USD 21,700 -
2025-12-08BUY79239.78038.600 38.718USD 30,665 -
2025-12-03BUY1,18840.06039.330 39.403USD 46,811 -
2025-12-02BUY29740.21039.495 39.566USD 11,751 -
2025-11-24BUY157,26239.83037.310 37.562USD 5,907,075 -
2025-11-18BUY39039.51038.985 39.038USD 15,225 -
2025-11-10BUY31239.39938.510 38.599USD 12,043 -
2025-11-07BUY54640.10038.390 38.561USD 21,054 -
2025-11-05BUY39040.81536.027 36.506USD 14,237 -
2025-11-04BUY2,34038.08036.755 36.888USD 86,317 -
2025-11-03BUY1,63837.71537.130 37.189USD 60,915 -
2025-10-31BUY93637.61036.670 36.764USD 34,411 -
2025-10-30BUY23437.21036.454 36.530USD 8,548 -
2025-10-29BUY70236.67036.980 36.949USD 25,938 -
2025-10-24BUY85837.26037.395 37.382USD 32,073 -
2025-10-20BUY54636.63036.920 36.891USD 20,142 -
2025-10-17BUY70237.01037.130 37.118USD 26,057 -
2025-10-03BUY54636.07036.670 36.610USD 19,989 -
2025-10-01BUY54636.32036.455 36.442USD 19,897 -
2025-09-26SELL-3,43235.04035.220 35.202USD -120,813 -
2025-09-18BUY62435.73035.810 35.802USD 22,340 -
2025-08-21BUY23436.31036.900 36.841USD 8,621 -
2025-08-20BUY39036.88036.890 36.889USD 14,387 -
2025-07-23BUY70236.01036.220 36.199USD 25,412 -
2025-07-22BUY39036.10036.140 36.136USD 14,093 -
2025-07-18BUY23435.59035.650 35.644USD 8,341 -
2025-07-16BUY31235.60036.890 36.761USD 11,469 -
2025-07-11BUY31235.84036.080 36.056USD 11,249 -
2025-07-09BUY46835.87035.900 35.897USD 16,800 -
2025-07-08BUY23435.51035.910 35.870USD 8,394 -
2025-07-02BUY1,40436.19036.245 36.239USD 50,880 -
2025-06-30BUY1,92536.03036.220 36.201USD 69,687 -
2025-06-18BUY53234.91034.990 34.982USD 18,610 -
2025-06-04BUY1,52033.44033.715 33.688USD 51,205 -
2025-06-03BUY22533.29033.540 33.515USD 7,541 -
2025-05-09BUY35033.15033.720 33.663USD 11,782 -
2025-05-06BUY41432.11033.040 32.947USD 13,640 -
2025-04-30BUY28432.82033.000 32.982USD 9,367 -
2025-04-25BUY71032.20032.300 32.290USD 22,926 -
2025-04-24BUY56032.03032.130 32.120USD 17,987 -
2025-04-23BUY28031.69032.480 32.401USD 9,072 -
2025-04-17BUY42632.60032.665 32.659USD 13,913 -
2025-04-16BUY56832.19032.610 32.568USD 18,499 -
2025-04-15BUY1,19032.45032.505 32.500USD 38,674 -
2025-04-14BUY49732.29032.320 32.317USD 16,062 -
2025-04-11BUY1,19031.95032.005 32.000USD 38,079 -
2025-04-10BUY28431.21031.970 31.894USD 9,058 -
2025-04-09BUY1,75532.27032.310 32.306USD 56,697 -
2025-04-08SELL-12230.85031.600 31.525USD -3,846 -
2025-04-07SELL-35031.03031.140 31.129USD -10,895 -
2025-04-04BUY42631.11031.700 31.641USD 13,479 -
2025-03-31BUY1,98831.13031.310 31.292USD 62,208 -
2025-03-27BUY42031.65032.250 32.190USD 13,520 -
2025-03-26BUY1,40031.56034.000 33.756USD 47,258 -
2025-03-24BUY35033.75033.990 33.966USD 11,888 -
2025-03-19BUY63033.41033.500 33.491USD 21,099 -
2025-03-17BUY1,19033.02033.265 33.240USD 39,556 -
2025-03-11BUY85232.46032.770 32.739USD 27,894 -
2025-03-07BUY21033.01033.720 33.649USD 7,066 -
2025-03-05BUY84033.77033.790 33.788USD 28,382 -
2025-03-04BUY56033.32034.060 33.986USD 19,032 -
2025-02-26BUY28033.38033.870 33.821USD 9,470 -
2025-02-25BUY49033.69034.115 34.073USD 16,696 -
2025-02-24BUY49033.80034.200 34.160USD 16,738 -
2025-02-18BUY1,96032.85032.870 32.868USD 64,421 -
2025-02-14BUY42032.36032.890 32.837USD 13,792 -
2025-02-13BUY70032.46032.630 32.613USD 22,829 -
2025-02-12BUY56032.34032.560 32.538USD 18,221 -
2025-02-10BUY21031.72031.790 31.783USD 6,674 -
2025-02-06BUY21031.40031.625 31.602USD 6,637 -
2025-02-05BUY42031.45031.635 31.617USD 13,279 -
2025-02-04BUY49031.26031.600 31.566USD 15,467 -
2025-01-31BUY21331.58031.678 31.668USD 6,745 -
2024-12-10BUY1,61725.59026.050 26.004USD 42,048 -
2024-12-09BUY1,23226.01026.220 26.199USD 32,277 -
2024-12-06BUY84725.91026.590 26.522USD 22,464 -
2024-12-05BUY1,46326.39026.540 26.525USD 38,806 -
2024-12-04BUY61626.10026.355 26.329USD 16,219 -
2024-12-03BUY1,23226.34026.470 26.457USD 32,595 -
2024-12-02BUY1,54026.43026.600 26.583USD 40,938 -
2024-11-29BUY1,38626.66026.660 26.660USD 36,951 -
2024-11-27BUY61626.60026.645 26.641USD 16,411 -
2024-11-26BUY1,77126.29026.620 26.587USD 47,086 -
2024-11-25BUY15426.47026.830 26.794USD 4,126 -
2024-11-21BUY61626.40026.665 26.639USD 16,409 -
2024-11-20BUY1,00126.22026.290 26.283USD 26,309 -
2024-11-19BUY69326.01026.030 26.028USD 18,037 -
2024-11-18BUY2,46425.80025.940 25.926USD 63,882 -
2024-11-11BUY1,00126.36026.600 26.576USD 26,603 -
2024-11-08BUY69326.21026.800 26.741USD 18,532 -
2024-11-07BUY77026.52027.030 26.979USD 20,774 -
2024-11-06BUY38526.64028.360 28.188USD 10,852 -
2024-11-05BUY1,23227.54027.565 27.563USD 33,957 -
2024-11-01BUY1,15527.10027.270 27.253USD 31,477 -
2024-10-31BUY61627.00027.260 27.234USD 16,776 -
2024-10-30BUY38527.19027.370 27.352USD 10,531 -
2024-10-29BUY53627.15027.330 27.312USD 14,639 -
2024-10-28BUY61627.26027.275 27.273USD 16,800 -
2024-10-21BUY61627.75028.000 27.975USD 17,233 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19877,43501,269,34869.1%
2025-09-18854,1562551,225,70969.7%
2025-09-17890,42801,130,88978.7%
2025-09-16849,69101,371,04262.0%
2025-09-151,310,0518751,800,47672.8%
2025-09-121,066,1208001,339,29279.6%
2025-09-111,220,1202831,532,65679.6%
2025-09-101,195,1197901,440,33383.0%
2025-09-091,259,8539241,521,80482.8%
2025-09-081,967,2801,0943,312,54759.4%
2025-09-052,792,92604,789,48758.3%
2025-09-04649,49701,396,64246.5%
2025-09-03741,51103,964,24418.7%
2025-09-021,164,4616211,836,12263.4%
2025-08-29568,8486441,099,44151.7%
2025-08-28343,4431,229665,67251.6%
2025-08-27718,529151,134,79763.3%
2025-08-26376,8063,158782,11648.2%
2025-08-25523,36001,666,11631.4%
2025-08-22416,9751,403983,55642.4%
2025-08-21515,9061789,60565.3%
2025-08-20668,9345571,359,61949.2%
2025-08-19282,3631,211801,13935.2%
2025-08-18470,777713735,14364.0%
2025-08-15370,8860849,95543.6%
2025-08-14437,27101,270,82534.4%
2025-08-13450,93002,187,21920.6%
2025-08-12378,7083211,366,73627.7%
2025-08-11566,6033221,321,77142.9%
2025-08-08732,3041,1411,058,55269.2%
2025-08-07637,7791411,478,11943.1%
2025-08-06968,026951,335,30672.5%
2025-08-05817,147971,153,95670.8%
2025-08-04562,562677830,96467.7%
2025-08-01356,771847641,24655.6%
2025-07-31550,713210657,91283.7%
2025-07-30529,655432816,35164.9%
2025-07-29600,85925752,37279.9%
2025-07-28682,7281,073824,97582.8%
2025-07-25351,99350514,20168.5%
2025-07-24396,41057557,22971.1%
2025-07-23289,2172,996787,22036.7%
2025-07-22460,4210666,17169.1%
2025-07-21489,8451,682693,05470.7%
2025-07-18355,3760587,43460.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy